As November approaches, a month best known for Thanksgiving and harvest festivals, it is also time to take a look at promising new therapies awaiting the FDA's verdict.So far this year (January-October), the U.S. regulatory agency has greenlighted 34 novel drugs compared to 38 approved during the same time frame last year.
Listed below are biotech stocks to keep an eye on as they approach a key regulatory catalyst this November.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.